arrow
J

Jean-Antoine Ribeil

sanofi usa
H指数:35
被引数:5,180

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In Vivo HSC Gene Editing for Correction of the Sickle Cell Mutation Using RNA Gene Writers

体内HSC基因编辑以纠正镰状细胞突变,使用RNA基因写入者

BLOOD
IF23.1
2024-11-050
PRE
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial
2022-01-2463
PRE
Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial
2020-06-0325
OAAI
Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study
2018-10-1870
OAAI
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

输血依赖性 β-地中海贫血患者的基因治疗

2018-04-19539
OAAI
Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory
2018-04-1710
OAAI
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
2018-02-2291
OAAI
Gene Therapy in a Patient with Sickle Cell Disease

镰状细胞病患者的基因治疗

2017-03-02559
OAAI
Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes
2016-12-0717
OAAI
Mixed Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation in Sickle Cell Disease: Preliminary Results on Peripheral Blood Sorted Subpopulations and Erythroid Progenitors
2016-05-010
OAAI